Matthew R Patterson Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew R Patterson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew R Patterson. Matthew R Patterson is Acting CEO & President in AMICUS THERAPEUTICS INC ($FOLD) and Chief Operating Officer in AMICUS THERAPEUTICS INC ($FOLD) and Chief Executive Officer in Audentes Therapeutics, Inc. ($BOLD) and President & CEO in Audentes Therapeutics, Inc. ($BOLD) and Director in Homology Medicines, Inc. ($FIXX) and Director in Vor Biopharma Inc. ($VOR) and Director in 5:01 Acquisition Corp. ($FVAM).
Latest Insider Trading Transactions of Matthew R Patterson
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FVAM, FOLD, BOLD, FIXX, VOR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | FIXX | Homology Medicines ... | Patterson Matthew R | Director | Option Exercise | A | 7.26 | 18,000 | 130,680 | 18,000 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Patterson Matthew R | Director | Option Exercise | A | 18.00 | 16,900 | 304,200 | 16,900 | |
| Oct 20 2020 | FVAM | 5:01 Acquisition C ... | Patterson Matthew R | Director | Option Exercise | J | 0.00 | 30,000 | 0 | 30,000 | |
| Oct 20 2020 | FVAM | 5:01 Acquisition C ... | Patterson Matthew R | Director | Option Exercise | J | 0.00 | 30,000 | 0 | 30,000 | |
| Jun 12 2020 | FIXX | Homology Medicines ... | Patterson Matthew R | Director | Option Exercise | A | 16.32 | 18,000 | 293,760 | 18,000 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | D | 24.74 | 177,450 | 4,390,113 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | D | 27.39 | 225,000 | 6,162,750 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | D | 15.26 | 188,334 | 2,873,977 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | D | 9.50 | 143,569 | 1,363,733 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | U | 60.00 | 171,814 | 10,308,840 | 0 | 171.8 K to 0 (-100.00 %) |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | U | 60.00 | 261,458 | 15,687,480 | 0 | 261.5 K to 0 (-100.00 %) |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 15.26 | 11,666 | 178,023 | 188,334 | |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 9.50 | 11,824 | 112,328 | 143,569 | |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 2.19 | 74,297 | 162,710 | 0 | |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 64,751 | 50,506 | 0 | |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 15.26 | 11,666 | 178,023 | 261,458 | 249.8 K to 261.5 K (+4.67 %) |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 9.50 | 11,824 | 112,328 | 249,792 | 238 K to 249.8 K (+4.97 %) |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 2.19 | 74,297 | 162,710 | 237,968 | 163.7 K to 238 K (+45.39 %) |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 64,751 | 50,506 | 163,671 | 98.9 K to 163.7 K (+65.46 %) |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Gift | G | 0.00 | 12,500 | 0 | 98,920 | 111.4 K to 98.9 K (-11.22 %) |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 15.26 | 11,666 | 178,023 | 188,334 | |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 9.50 | 11,824 | 112,328 | 143,569 | |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 2.19 | 74,297 | 162,710 | 0 | |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 64,751 | 50,506 | 0 | |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 15.26 | 11,666 | 178,023 | 261,458 | 249.8 K to 261.5 K (+4.67 %) |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 9.50 | 11,824 | 112,328 | 249,792 | 238 K to 249.8 K (+4.97 %) |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 2.19 | 74,297 | 162,710 | 237,968 | 163.7 K to 238 K (+45.39 %) |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 64,751 | 50,506 | 163,671 | 98.9 K to 163.7 K (+65.46 %) |
| Jan 10 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Gift | G | 0.00 | 12,500 | 0 | 98,920 | 111.4 K to 98.9 K (-11.22 %) |
| Dec 09 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Payment of Exercise | F | 59.21 | 1,974 | 116,881 | 111,420 | 113.4 K to 111.4 K (-1.74 %) |
| Nov 12 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 9.50 | 14,426 | 137,047 | 155,393 | |
| Nov 12 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 30.00 | 14,426 | 432,780 | 113,394 | 127.8 K to 113.4 K (-11.29 %) |
| Nov 12 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 9.50 | 14,426 | 137,047 | 127,820 | 113.4 K to 127.8 K (+12.72 %) |
| Sep 09 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Payment of Exercise | F | 31.02 | 1,974 | 61,233 | 113,394 | 115.4 K to 113.4 K (-1.71 %) |
| Aug 14 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 9.50 | 20,000 | 190,000 | 169,819 | |
| Aug 14 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 34.53 | 1,000 | 34,525 | 115,368 | 116.4 K to 115.4 K (-0.86 %) |
| Aug 14 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 34.02 | 19,000 | 646,310 | 116,368 | 135.4 K to 116.4 K (-14.04 %) |
| Aug 14 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 9.50 | 20,000 | 190,000 | 135,368 | 115.4 K to 135.4 K (+17.34 %) |
| Jun 10 2019 | FIXX | Homology Medicines ... | Patterson Matthew R | Director | Option Exercise | A | 19.51 | 15,580 | 303,966 | 15,580 | |
| Jun 07 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Payment of Exercise | F | 37.31 | 3,332 | 124,317 | 115,368 | 118.7 K to 115.4 K (-2.81 %) |
| Jun 07 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Payment of Exercise | F | 37.31 | 3,332 | 124,317 | 115,368 | 118.7 K to 115.4 K (-2.81 %) |
| Feb 27 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 2.19 | 4,000 | 8,760 | 74,297 | |
| Feb 27 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 17,000 | 13,260 | 64,751 | |
| Feb 27 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 30.00 | 4,000 | 120,000 | 118,700 | 122.7 K to 118.7 K (-3.26 %) |
| Feb 27 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 2.19 | 4,000 | 8,760 | 122,700 | 118.7 K to 122.7 K (+3.37 %) |
| Feb 27 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 30.00 | 17,000 | 510,000 | 118,700 | 135.7 K to 118.7 K (-12.53 %) |
| Feb 27 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 17,000 | 13,260 | 135,700 | 118.7 K to 135.7 K (+14.32 %) |
| Feb 08 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | A | 24.74 | 177,450 | 4,390,113 | 177,450 | |
| Feb 08 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Grant | A | 0.00 | 63,700 | 0 | 118,700 | 55 K to 118.7 K (+115.82 %) |
| Dec 10 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 40,000 | 31,200 | 31,702 | |
| Dec 10 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 40,000 | 31,200 | 55,000 | 15 K to 55 K (+266.67 %) |
| Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 21,000 | 16,380 | 71,702 | |
| Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 37.70 | 8,078 | 304,573 | 15,000 | 23.1 K to 15 K (-35.00 %) |
| Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 8,078 | 6,301 | 23,078 | 15 K to 23.1 K (+53.85 %) |
| Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 38.58 | 5,448 | 210,162 | 15,000 | 20.4 K to 15 K (-26.64 %) |
| Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 5,448 | 4,249 | 20,448 | 15 K to 20.4 K (+36.32 %) |
| Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 38.04 | 5,330 | 202,732 | 15,000 | 20.3 K to 15 K (-26.22 %) |
| Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 5,330 | 4,157 | 20,330 | 15 K to 20.3 K (+35.53 %) |
| Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 39.14 | 2,144 | 83,905 | 15,000 | 17.1 K to 15 K (-12.51 %) |
| Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 2,144 | 1,672 | 17,144 | 15 K to 17.1 K (+14.29 %) |
| Sep 24 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 15,000 | 11,700 | 92,702 | |
| Sep 24 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 15,000 | 11,700 | 15,000 | 0 to 15 K |
| Sep 20 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 2.19 | 12,952 | 28,365 | 128,345 | |
| Sep 20 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 40.00 | 12,952 | 518,080 | 0 | 13 K to 0 (-100.00 %) |
| Sep 20 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 2.19 | 12,952 | 28,365 | 12,952 | 0 to 13 K |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 23,147 | 18,055 | 107,702 | |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 26,901 | 20,983 | 130,849 | |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 1,401 | 1,093 | 157,750 | |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 19,599 | 15,287 | 159,151 | |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 40.04 | 23,147 | 926,852 | 0 | 23.1 K to 0 (-100.00 %) |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 23,147 | 18,055 | 23,147 | 0 to 23.1 K |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 40.05 | 26,901 | 1,077,460 | 0 | 26.9 K to 0 (-100.00 %) |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 26,901 | 20,983 | 26,901 | 0 to 26.9 K |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 38.78 | 1,401 | 54,330 | 0 | 1.4 K to 0 (-100.00 %) |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 1,401 | 1,093 | 1,401 | 0 to 1.4 K |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 38.33 | 19,599 | 751,194 | 0 | 19.6 K to 0 (-100.00 %) |
| Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 19,599 | 15,287 | 19,599 | 0 to 19.6 K |
| May 23 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 20,300 | 15,834 | 178,750 | |
| May 23 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 38.30 | 6,700 | 256,610 | 0 | 6.7 K to 0 (-100.00 %) |
| May 23 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 6,700 | 5,226 | 6,700 | 0 to 6.7 K |
| May 23 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 38.08 | 13,600 | 517,888 | 0 | 13.6 K to 0 (-100.00 %) |
| May 23 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 13,600 | 10,608 | 13,600 | 0 to 13.6 K |
| Apr 04 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 700 | 546 | 199,050 | |
| Apr 04 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 30.01 | 700 | 21,009 | 0 | 700 to 0 (-100.00 %) |
| Apr 04 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 700 | 546 | 700 | 0 to 700 |
| Mar 29 2018 | FIXX | Homology Medicines ... | Patterson Matthew R | Director | Option Exercise | A | 16.00 | 8,360 | 133,760 | 8,360 | |
| Nov 17 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | A | 27.39 | 225,000 | 6,162,750 | 225,000 | |
| Oct 04 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 10,000 | 7,800 | 199,750 | |
| Oct 04 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 27.92 | 15,000 | 418,853 | 171,814 | 186.8 K to 171.8 K (-8.03 %) |
| Oct 04 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 27.92 | 10,000 | 279,217 | 0 | 10 K to 0 (-100.00 %) |
| Oct 04 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 10,000 | 7,800 | 10,000 | 0 to 10 K |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 8,458 | 6,597 | 209,750 | |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 1,542 | 1,203 | 218,208 | |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 25.07 | 8,458 | 212,010 | 0 | 8.5 K to 0 (-100.00 %) |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 8,458 | 6,597 | 8,458 | 0 to 8.5 K |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 25.00 | 1,542 | 38,551 | 0 | 1.5 K to 0 (-100.00 %) |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 1,542 | 1,203 | 1,542 | 0 to 1.5 K |
| Jul 14 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 20.00 | 12,150 | 243,052 | 186,814 | 199 K to 186.8 K (-6.11 %) |
| Jul 14 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 20.00 | 2,850 | 57,007 | 198,964 | 201.8 K to 199 K (-1.41 %) |
| Jan 27 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | A | 15.26 | 200,000 | 3,052,000 | 200,000 | |
| Apr 19 2011 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Acting CEO & Presid ... | Grant | A | 0.00 | 50,000 | 0 | 106,547 | 56.5 K to 106.5 K (+88.42 %) |
| Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Option Exercise | A | 5.96 | 50,000 | 298,000 | 50,000 | |
| Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Option Exercise | A | 2.81 | 30,000 | 84,300 | 30,000 | |
| Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Option Exercise | A | 4.16 | 80,000 | 332,800 | 80,000 | |
| Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Option Exercise | A | 10.36 | 54,000 | 559,440 | 54,000 | |
| Dec 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Option Exercise | M | 0.64 | 20,098 | 12,823 | 0 | |
| Dec 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Buy | M | 0.64 | 20,098 | 12,823 | 56,547 | 36.4 K to 56.5 K (+55.14 %) |
| Nov 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.00 | 1,939 | 19,390 | 36,449 | 38.4 K to 36.4 K (-5.05 %) |
| Nov 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.00 | 361 | 3,610 | 38,388 | 38.7 K to 38.4 K (-0.93 %) |
| Oct 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.10 | 100 | 1,010 | 38,749 | 38.8 K to 38.7 K (-0.26 %) |
| Oct 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.40 | 3,100 | 32,246 | 38,849 | 41.9 K to 38.8 K (-7.39 %) |
| Oct 22 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.51 | 2,500 | 26,263 | 41,949 | 44.4 K to 41.9 K (-5.62 %) |
| Oct 22 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.51 | 100 | 1,151 | 44,449 | 44.5 K to 44.4 K (-0.22 %) |
| Oct 22 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.73 | 1,900 | 20,393 | 44,549 | 46.4 K to 44.5 K (-4.09 %) |
| Aug 21 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 13.54 | 2,000 | 27,070 | 46,449 | 48.4 K to 46.4 K (-4.13 %) |
| Aug 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 14.50 | 700 | 10,149 | 48,449 | 49.1 K to 48.4 K (-1.42 %) |
| Aug 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 13.71 | 3,800 | 52,094 | 49,149 | 52.9 K to 49.1 K (-7.18 %) |
| Aug 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 16.04 | 800 | 12,834 | 52,949 | 53.7 K to 52.9 K (-1.49 %) |
| Aug 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 15.02 | 2,700 | 40,554 | 53,749 | 56.4 K to 53.7 K (-4.78 %) |
| Jun 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.54 | 400 | 4,616 | 58,549 | 58.9 K to 58.5 K (-0.68 %) |
| Jun 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.50 | 200 | 2,300 | 58,949 | 59.1 K to 58.9 K (-0.34 %) |
| Jun 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.35 | 400 | 4,540 | 59,149 | 59.5 K to 59.1 K (-0.67 %) |
| Jun 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.26 | 123 | 1,385 | 59,549 | 59.7 K to 59.5 K (-0.21 %) |
| Jun 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.25 | 277 | 3,116 | 59,672 | 59.9 K to 59.7 K (-0.46 %) |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.11 | 14 | 156 | 59,949 | 60 K to 59.9 K (-0.02 %) |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.03 | 300 | 3,309 | 59,963 | 60.3 K to 60 K (-0.50 %) |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.02 | 86 | 948 | 60,263 | 60.3 K to 60.3 K (-0.14 %) |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.12 | 100 | 1,112 | 60,349 | 60.4 K to 60.3 K (-0.17 %) |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.02 | 200 | 2,204 | 60,449 | 60.6 K to 60.4 K (-0.33 %) |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.01 | 200 | 2,202 | 60,649 | 60.8 K to 60.6 K (-0.33 %) |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.00 | 400 | 4,400 | 60,849 | 61.2 K to 60.8 K (-0.65 %) |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.99 | 100 | 1,099 | 61,249 | 61.3 K to 61.2 K (-0.16 %) |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.97 | 400 | 4,388 | 61,349 | 61.7 K to 61.3 K (-0.65 %) |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.95 | 100 | 1,095 | 61,749 | 61.8 K to 61.7 K (-0.16 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.20 | 100 | 1,120 | 59,749 | 59.8 K to 59.7 K (-0.17 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.16 | 100 | 1,116 | 59,849 | 59.9 K to 59.8 K (-0.17 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.15 | 300 | 3,345 | 59,949 | 60.2 K to 59.9 K (-0.50 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.08 | 10 | 111 | 60,249 | 60.3 K to 60.2 K (-0.02 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.07 | 100 | 1,107 | 60,259 | 60.4 K to 60.3 K (-0.17 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.06 | 100 | 1,106 | 60,359 | 60.5 K to 60.4 K (-0.17 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.05 | 500 | 5,525 | 60,459 | 61 K to 60.5 K (-0.82 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.03 | 100 | 1,103 | 60,959 | 61.1 K to 61 K (-0.16 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.01 | 100 | 1,101 | 61,059 | 61.2 K to 61.1 K (-0.16 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.00 | 390 | 4,290 | 61,159 | 61.5 K to 61.2 K (-0.63 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.25 | 100 | 1,125 | 61,549 | 61.6 K to 61.5 K (-0.16 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.23 | 200 | 2,246 | 61,649 | 61.8 K to 61.6 K (-0.32 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.22 | 400 | 4,488 | 61,849 | 62.2 K to 61.8 K (-0.64 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.21 | 1,043 | 11,692 | 62,249 | 63.3 K to 62.2 K (-1.65 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.20 | 500 | 5,600 | 63,292 | 63.8 K to 63.3 K (-0.78 %) |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.19 | 857 | 9,590 | 63,792 | 64.6 K to 63.8 K (-1.33 %) |